Literature DB >> 30836154

A comparison of the immune responses induced by antigens in three different archaeosome-based vaccine formulations.

Yimei Jia1, Bassel Akache2, Lise Deschatelets3, Hui Qian4, Renu Dudani5, Blair A Harrison6, Felicity C Stark7, Vandana Chandan8, Mohammad P Jamshidi9, Lakshmi Krishnan10, Michael J McCluskie11.   

Abstract

Archaeosomes are liposomes composed of natural or synthetic archaeal lipids that can be used as adjuvants to induce strong long-lasting humoral and cell-mediated immune responses against entrapped antigen. However, the entrapment efficiency of antigen within archaeosomes constituted using standard liposome forming methodology is often only 5-40%. In this study, we evaluated different formulation methods using a simple semi-synthetic archaeal lipid (SLA, sulfated lactosyl archaeol) and two different antigens, ovalbumin (OVA) and hepatitis B surface antigen (HBsAg). Antigen was entrapped within archaeosomes using the conventional thin film hydration-rehydration method with or without removal of non-entrapped antigen, or pre-formed empty archaeosomes were simply admixed with an antigen solution. Physicochemical characteristics were determined (size distribution, zeta potential, vesicle morphology and lamellarity), as well as location of antigen relative to bilayer using cryogenic transmission electron microscopy (TEM). We demonstrate that antigen (OVA or HBsAg) formulated with SLA lipid adjuvants using all the different methodologies resulted in a strong antigen-specific immune response. Nevertheless, the advantage of using a drug substance process that comprises of simply admixing antigen with pre-formed empty archaeosomes, represents a simple, efficient and antigenic dose-sparing formulation for adjuvanting and delivering vaccine antigens. Crown
Copyright © 2019. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Adjuvant; Admixed; Archaeosome; Glycolipid; Liposome; Vaccine

Mesh:

Substances:

Year:  2019        PMID: 30836154     DOI: 10.1016/j.ijpharm.2019.02.041

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  10 in total

Review 1.  Adjuvants: Engineering Protective Immune Responses in Human and Veterinary Vaccines.

Authors:  Bassel Akache; Felicity C Stark; Gerard Agbayani; Tyler M Renner; Michael J McCluskie
Journal:  Methods Mol Biol       Date:  2022

Review 2.  Methanogenic Archaea: Emerging Partners in the Field of Allergic Diseases.

Authors:  Youssouf Sereme; Soraya Mezouar; Ghiles Grine; Jean Louis Mege; Michel Drancourt; Pierre Corbeau; Joana Vitte
Journal:  Clin Rev Allergy Immunol       Date:  2019-12       Impact factor: 8.667

3.  Simplified Admix Archaeal Glycolipid Adjuvanted Vaccine and Checkpoint Inhibitor Therapy Combination Enhances Protection from Murine Melanoma.

Authors:  Felicity C Stark; Gerard Agbayani; Jagdeep K Sandhu; Bassel Akache; Charis McPherson; Lise Deschatelets; Renu Dudani; Melissa Hewitt; Yimei Jia; Lakshmi Krishnan; Michael J McCluskie
Journal:  Biomedicines       Date:  2019-11-23

4.  Adjuvanted Schistosoma mansoni-Cathepsin B With Sulfated Lactosyl Archaeol Archaeosomes or AddaVax™ Provides Protection in a Pre-Clinical Schistosomiasis Model.

Authors:  Dilhan J Perera; Adam S Hassan; Yimei Jia; Alessandra Ricciardi; Michael J McCluskie; Risini D Weeratna; Momar Ndao
Journal:  Front Immunol       Date:  2020-11-16       Impact factor: 7.561

5.  The Synergistic Effects of Sulfated Lactosyl Archaeol Archaeosomes When Combined with Different Adjuvants in a Murine Model.

Authors:  Yimei Jia; Bassel Akache; Gerard Agbayani; Vandana Chandan; Renu Dudani; Blair A Harrison; Lise Deschatelets; Usha D Hemraz; Edmond Lam; Sophie Régnier; Felicity C Stark; Lakshmi Krishnan; Michael J McCluskie
Journal:  Pharmaceutics       Date:  2021-02-02       Impact factor: 6.321

6.  Immunogenic and efficacious SARS-CoV-2 vaccine based on resistin-trimerized spike antigen SmT1 and SLA archaeosome adjuvant.

Authors:  Bassel Akache; Tyler M Renner; Anh Tran; Lise Deschatelets; Renu Dudani; Blair A Harrison; Diana Duque; Julie Haukenfrers; Martin A Rossotti; Francis Gaudreault; Usha D Hemraz; Edmond Lam; Sophie Régnier; Wangxue Chen; Christian Gervais; Matthew Stuible; Lakshmi Krishnan; Yves Durocher; Michael J McCluskie
Journal:  Sci Rep       Date:  2021-11-08       Impact factor: 4.996

Review 7.  Vesicular and Planar Membranes of Archaea Lipids: Unusual Physical Properties and Biomedical Applications.

Authors:  Parkson Lee-Gau Chong; Abby Chang; Allyson Yu; Ayna Mammedova
Journal:  Int J Mol Sci       Date:  2022-07-09       Impact factor: 6.208

8.  Immunogenicity of SARS-CoV-2 spike antigens derived from Beta & Delta variants of concern.

Authors:  Bassel Akache; Tyler M Renner; Matthew Stuible; Nazanin Rohani; Yuneivy Cepero-Donates; Lise Deschatelets; Renu Dudani; Blair A Harrison; Christian Gervais; Jennifer J Hill; Usha D Hemraz; Edmond Lam; Sophie Régnier; Anne E G Lenferink; Yves Durocher; Michael J McCluskie
Journal:  NPJ Vaccines       Date:  2022-10-12       Impact factor: 9.399

9.  Mechanistic insight into the induction of cellular immune responses by encapsulated and admixed archaeosome-based vaccine formulations.

Authors:  Gerard Agbayani; Yimei Jia; Bassel Akache; Vandana Chandan; Umar Iqbal; Felicity C Stark; Lise Deschatelets; Edmond Lam; Usha D Hemraz; Sophie Régnier; Lakshmi Krishnan; Michael J McCluskie
Journal:  Hum Vaccin Immunother       Date:  2020-08-05       Impact factor: 3.452

Review 10.  Archaeosomes and Gas Vesicles as Tools for Vaccine Development.

Authors:  Natalia Adamiak; Krzysztof T Krawczyk; Camille Locht; Magdalena Kowalewicz-Kulbat
Journal:  Front Immunol       Date:  2021-09-10       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.